IL141312A0 - Method for recovering proteins from the interstitial fluid of plant tissues - Google Patents

Method for recovering proteins from the interstitial fluid of plant tissues

Info

Publication number
IL141312A0
IL141312A0 IL14131299A IL14131299A IL141312A0 IL 141312 A0 IL141312 A0 IL 141312A0 IL 14131299 A IL14131299 A IL 14131299A IL 14131299 A IL14131299 A IL 14131299A IL 141312 A0 IL141312 A0 IL 141312A0
Authority
IL
Israel
Prior art keywords
proteins
interstitial fluid
plant tissues
recovering proteins
plants
Prior art date
Application number
IL14131299A
Other languages
English (en)
Original Assignee
Biosource Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosource Tech Inc filed Critical Biosource Tech Inc
Publication of IL141312A0 publication Critical patent/IL141312A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2422—Alpha-amylase (3.2.1.1.) from plant source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13—Immunoglobulins specific features characterized by their source of isolation or production isolated from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
IL14131299A 1998-08-11 1999-08-11 Method for recovering proteins from the interstitial fluid of plant tissues IL141312A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13298998A 1998-08-11 1998-08-11
PCT/US1999/018161 WO2000009725A2 (en) 1998-08-11 1999-08-11 Method for recovering proteins from the interstitial fluid of plant tissues

Publications (1)

Publication Number Publication Date
IL141312A0 true IL141312A0 (en) 2002-03-10

Family

ID=22456515

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14131299A IL141312A0 (en) 1998-08-11 1999-08-11 Method for recovering proteins from the interstitial fluid of plant tissues

Country Status (14)

Country Link
US (5) US6284875B1 (xx)
EP (1) EP1104479B1 (xx)
JP (1) JP2002522559A (xx)
KR (1) KR20010072372A (xx)
AT (1) ATE342994T1 (xx)
AU (1) AU759813B2 (xx)
BR (1) BR9912875A (xx)
CA (1) CA2349852A1 (xx)
DE (1) DE69933677T2 (xx)
IL (1) IL141312A0 (xx)
MX (1) MXPA01001445A (xx)
NZ (1) NZ510358A (xx)
WO (1) WO2000009725A2 (xx)
ZA (1) ZA200101100B (xx)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9912875A (pt) * 1998-08-11 2002-02-13 Large Scale Biology Corp Método para a recuperação de proteìnas a partir do fluido intersticial de tecidos vegetais
IL147343A0 (en) * 1999-07-21 2002-08-14 Large Scale Biology Corp Method for enhancing ran or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
EP1349946B1 (en) 2000-08-25 2011-01-26 BASF Plant Science GmbH Plant polynucleotides encoding prenyl proteases
US7629309B2 (en) * 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
ES2300439T3 (es) * 2001-04-30 2008-06-16 Zystor Therapeutics , Inc. Reconocimiento subcelular de proteinas terapeuticas.
US7560424B2 (en) 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US20040005309A1 (en) * 2002-05-29 2004-01-08 Symbiontics, Inc. Targeted therapeutic proteins
US20030072761A1 (en) * 2001-10-16 2003-04-17 Lebowitz Jonathan Methods and compositions for targeting proteins across the blood brain barrier
US6817970B2 (en) * 2002-06-17 2004-11-16 Large Scale Biology Corporation Centrifuge for extracting interstitial fluid
US7783159B2 (en) * 2002-06-24 2010-08-24 Lg Electronics Inc. Recording medium having data structure for managing reproduction of multiple reproduction path video data for at least a segment of a title recorded thereon and recording and reproducing methods and apparatuses
KR20040000290A (ko) * 2002-06-24 2004-01-03 엘지전자 주식회사 고밀도 광디스크의 멀티 경로 데이터 스트림 관리방법
EP1629090B1 (en) * 2002-11-06 2014-03-05 iBio, Inc. Expression of foreign sequences in plants using trans-activation system
US7692063B2 (en) * 2002-11-12 2010-04-06 Ibio, Inc. Production of foreign nucleic acids and polypeptides in sprout systems
US7683238B2 (en) * 2002-11-12 2010-03-23 iBio, Inc. and Fraunhofer USA, Inc. Production of pharmaceutically active proteins in sprouted seedlings
ES2531125T3 (es) * 2003-02-03 2015-03-10 Ibio Inc Sistema para la expresión de genes en plantas
US7809775B2 (en) * 2003-02-27 2010-10-05 Lg Electronics, Inc. Recording medium having data structure for managing playback control recorded thereon and recording and reproducing methods and apparatuses
EP1604356A4 (en) * 2003-02-28 2009-12-16 Lg Electronics Inc RECORD MEDIUM WITH A DATA STRUCTURE FOR MANAGING THE RANDOM / SHUFFLE PLAYBACK OF RECORDED VIDEO DATA, AND METHOD AND DEVICES FOR RECORDING AND PLAYING
CN103074316B (zh) 2003-05-22 2015-10-21 美国弗劳恩霍夫股份有限公司 用于表达、传递及纯化目标多肽的重组载体分子
US8158379B2 (en) * 2003-10-28 2012-04-17 Allosource Methods for determining microbial contamination of allograft products
AU2005212435B2 (en) * 2004-02-10 2010-09-09 Biomarin Pharmaceutical Inc. Acid alpha-glucosidase and fragments thereof
CA2555230A1 (en) 2004-02-20 2005-09-09 Fraunhofer Usa Inc. Systems and methods for clonal expression in plants
US20050220901A1 (en) * 2004-03-22 2005-10-06 Huttenbauer Samuel Jr Methods of pharmaceutical separation from plants
CA2570566A1 (en) 2004-06-25 2006-01-12 Altor Bioscience Corporation Production of tissue factor in plants
US20060288449A1 (en) * 2004-10-12 2006-12-21 Garger Stephen J Process for purifying target compounds from plant sources using ceramic filtration
WO2006130529A1 (en) * 2005-05-31 2006-12-07 Pierce Biotechnology, Inc. Extraction of cellular components with fatty acid derivatives
CN101378781B (zh) * 2005-08-03 2013-08-07 美国弗劳恩霍夫股份有限公司 制造免疫球蛋白的组合物和方法
EP1984388B1 (en) * 2006-02-13 2016-07-06 iBio, Inc. Hpv antigens, vaccine compositions, and related methods
US8124103B2 (en) * 2006-02-13 2012-02-28 Fraunhofer Usa, Inc Influenza antigens, vaccine compositions, and related methods
US8277816B2 (en) * 2006-02-13 2012-10-02 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
TW200745337A (en) * 2006-02-24 2007-12-16 Aminotech As Modified process
JP2010509344A (ja) * 2006-11-13 2010-03-25 ザイストール セラピューティクス， インコーポレイテッド ポンペ病を治療するための方法
EP2152301A4 (en) * 2007-04-28 2010-07-28 Fraunhofer Usa Inc TRYPANOSOME ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
US9321806B2 (en) * 2007-05-16 2016-04-26 University Of Maryland, College Park Methods for recovery of leaf proteins
US8404252B2 (en) * 2007-07-11 2013-03-26 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
US20110059130A1 (en) * 2007-08-20 2011-03-10 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
DK2610345T3 (en) 2007-11-27 2015-12-07 Medicago Inc RECOMBINANT INFLUENZA VIRUS SIMULAR PARTICULARS (VLPS) MADE IN TRANSGENE PLANTS THAT EXPRESS HEMAGGLUTININ
EP2113514A1 (de) 2008-05-03 2009-11-04 Westfälische Wilhelms-Universität Münster Verfahren zur Erzeugung von hypoallergenen Glykoproteinen in mutierten oder transgenen Pflanzen oder Pflanzenzellen sowie mutierte oder transgene Pflanzen und Pflanzenzellen zur Erzeugung hypoallergener Glykoproteine
BRPI0912225A2 (pt) * 2008-05-07 2018-03-20 Zystor Therapeutics, Inc. peptídeos de direcionamento lisossomais e usos dos mesmos
ES2545607T3 (es) 2008-07-08 2015-09-14 Medicago Inc. Antígenos de la gripe recombinantes solubles
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
EP3075386B1 (en) 2009-06-17 2019-10-16 BioMarin Pharmaceutical Inc. Formulations for lysosomal enzymes
MX349924B (es) 2009-06-24 2017-08-21 Medicago Inc * Partículas similares al virus de la influenza quiméricas que comprenden hemaglutinina.
IN2012DN02637A (xx) * 2009-09-22 2015-09-04 Medicago Inc
CA2776144C (en) 2009-09-29 2020-10-27 Fraunhofer Usa, Inc. Influenza hemagglutinin antibodies, compositions, and related methods
CN103180447A (zh) 2010-07-19 2013-06-26 加州大学评议会 异源蛋白质的植物基制备
US9155321B2 (en) 2010-08-11 2015-10-13 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
EP2632562B1 (en) * 2010-10-27 2020-08-05 Philip Morris Products S.a.s. Methods for capturing virus like particles from plants using expanded bed chromatography
US9220295B2 (en) 2010-12-01 2015-12-29 R.J. Reynolds Tobacco Company Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems
US9204667B2 (en) 2010-12-01 2015-12-08 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
US9775376B2 (en) 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
US20130118512A1 (en) 2011-11-16 2013-05-16 R.J. Reynolds Tobacco Company Smokeless tobacco products with starch component
US20130125904A1 (en) 2011-11-18 2013-05-23 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising pectin component
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
US20130206150A1 (en) 2012-02-10 2013-08-15 R.J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
US9339058B2 (en) 2012-04-19 2016-05-17 R. J. Reynolds Tobacco Company Method for producing microcrystalline cellulose from tobacco and related tobacco product
US9617297B2 (en) * 2012-10-11 2017-04-11 The Regents Of The University Of California Apoplast wash fluid recovery for improved recombinant endoglucanase extraction in tabacco leaves
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CN104195170B (zh) * 2014-09-16 2016-04-13 云南省农业科学院生物技术与种质资源研究所 一种水稻真空渗透遗传转化方法
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
US11612183B2 (en) 2015-12-10 2023-03-28 R.J. Reynolds Tobacco Company Protein-enriched tobacco composition
CA3041717A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
US10757964B2 (en) 2017-07-20 2020-09-01 R.J. Reynolds Tobacco Company Purification of tobacco-derived protein compositions
BE1025528B1 (fr) * 2017-09-06 2019-04-05 Universite De Liege Établissement Public De La Communauté Française De Belgique Dispositif non-destructif d'echantillon pour extraction de marqueurs
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
EP3801056A4 (en) 2018-05-30 2022-03-16 LeafPro, LLC. PURIFIED PROTEIN CONCENTRATES FROM SWEET POTATO LEAVES, AND METHODS OF RECOVERING THEM
US11312753B2 (en) * 2018-09-25 2022-04-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems to produce lignin-modifying enzymes and uses thereof
US11523623B2 (en) 2019-01-18 2022-12-13 R.J. Reynolds Tobacco Company Plant-derived protein purification
EP3808854A1 (de) * 2019-10-17 2021-04-21 eleva GmbH Verfahren zur gewinnung von material von pflanzenzelloberflächen
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
CN111004766B (zh) * 2019-12-30 2022-03-18 浙江大学 一种从植物叶片中提取纯化内质网及其蛋白的有效方法
CN116194461A (zh) * 2020-08-05 2023-05-30 电化株式会社 目标蛋白质的回收方法及制造方法
EP4326097A1 (en) 2021-04-22 2024-02-28 Nicoventures Trading Limited Oral compositions and methods of manufacture
US20220354785A1 (en) 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910822A (en) * 1974-03-14 1975-10-07 Us Health Isolation of glucocerebrosidase from human placental tissue
JPS5322158B2 (xx) * 1974-05-02 1978-07-06
JPS53107479A (en) * 1977-02-28 1978-09-19 Green Cross Corp:The Preparation of human lysozyme
US4885248A (en) 1984-02-15 1989-12-05 Lubrizol Genetics, Inc. Transfer vector
US5173410A (en) 1984-02-15 1992-12-22 Lubrizol Genetics Inc. Transfer vector
US5466788A (en) 1985-03-07 1995-11-14 Mycogen Plant Science, Inc. Subgenomic promoter
CA1288073C (en) 1985-03-07 1991-08-27 Paul G. Ahlquist Rna transformation vector
DE3850683T2 (de) 1987-02-09 1994-10-27 Lubrizol Genetics Inc Hybrides RNS-Virus.
US5316931A (en) 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
DE4016562A1 (de) * 1990-05-23 1991-11-28 Degussa Rohrverbindungsstuecke zur installation von rohrleitungen und verfahren zu ihrer herstellung
US5852172A (en) * 1991-06-13 1998-12-22 University Of Waterloo Cold tolerances in plants
US5597569A (en) * 1993-10-25 1997-01-28 Bristol-Myers Squibb Company Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica
CH688988A5 (de) * 1994-03-14 1998-07-15 Ferrum Ag Filterzentrifuge.
US5837826A (en) * 1995-02-27 1998-11-17 Regents Of The University Of Minnesota Protein adsorption by very dense porous zirconium oxide particles in expanded beds
ES2124176B1 (es) * 1996-10-07 1999-10-01 Univ Valladolid Procedimiento para la obtencion de proteinas inactivadoras de ribosomas, denominadas beetin 27 y beetin 29, de las hojas de beta vulgaris (remolacha azucarera) infectadas con el virus de la amarillez.
BR9912875A (pt) * 1998-08-11 2002-02-13 Large Scale Biology Corp Método para a recuperação de proteìnas a partir do fluido intersticial de tecidos vegetais

Also Published As

Publication number Publication date
US20040047923A1 (en) 2004-03-11
MXPA01001445A (es) 2002-11-29
US20030073209A1 (en) 2003-04-17
CA2349852A1 (en) 2000-02-24
KR20010072372A (ko) 2001-07-31
BR9912875A (pt) 2002-02-13
ZA200101100B (en) 2001-11-26
NZ510358A (en) 2002-09-27
AU5396799A (en) 2000-03-06
DE69933677T2 (de) 2007-08-23
US6284875B1 (en) 2001-09-04
WO2000009725A3 (en) 2000-05-18
AU759813B2 (en) 2003-05-01
EP1104479A2 (en) 2001-06-06
US6617435B2 (en) 2003-09-09
US20050059127A1 (en) 2005-03-17
EP1104479B1 (en) 2006-10-18
ATE342994T1 (de) 2006-11-15
US6841659B2 (en) 2005-01-11
US6441147B1 (en) 2002-08-27
DE69933677D1 (de) 2006-11-30
US7034128B2 (en) 2006-04-25
JP2002522559A (ja) 2002-07-23
WO2000009725A2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
IL141312A0 (en) Method for recovering proteins from the interstitial fluid of plant tissues
DK58789A (da) Proteiner med faktor viii-aktivitet, fremgangsmaade til deres fremstilling ved anvendelse af genetisk konstruerede celler og farmaceutiske kompositioner indeholdende proteinerne
SG2013021217A (en) Production of high mannose proteins in plant culture
ATE517185T1 (de) Methoden zur herstellung von pflanzen mit erhöhtem ölsäuregehalt
ES8505405A1 (es) Un procedimiento para producir un activador de plasminogeno purificado.
AU1550888A (en) Plant tissue transformation
MX349479B (es) Polinucleotidos y polipeptidos involucrados en el desarrollo de fibra vegetal y metodos de uso.
EP0156355A3 (en) Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
WO2000056905A3 (en) Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
DE60014635D1 (de) Verfahren zur expression und isolierung von rekombinanten proteinen und rekombinanten proteinprodukten von pflanzen, pflanzlichen geweben oder kultivierten pflanzenzellen
DK32684A (da) Fremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
TR200000086T2 (tr) Heparin üretimi için işlem.
DE50301559D1 (de) Verfahren zur herstellung von tocotrienol-angereicherten präparationen
CA2286801A1 (en) A novel process to produce stabilized carnosic acid in high concentration
WO1999058699A3 (en) Transgenic plant-derived human blood coagulation factors
AU4748500A (en) Method for obtaining recombinant hbsag
DK1019512T3 (da) Fremgangsmåde til fremstilling af forgrenede fedtsyrer ved hjælp af genetisk modificerede planter
IL158244A0 (en) Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
DK1520012T3 (da) Monopropylenglycol tilsat til fermenteringsmedium
JPS55315A (en) Novel preparation of natural lysolecithin
NZ329018A (en) Extracting glycogen from Green Shell Mussels and the use of the glycogen as a food supplement or additive or in the treatment of inflammatory diseases such as arthritis.
SU1117013A1 (ru) Способ получени изолированных алейроновых зерен растений риса
WO2004046199A3 (fr) Procede d'obtention d'acide chondroitine sulfurique et ses utilisations
Honda et al. Proteolytic Digestion of Apoproteins of Light-Harvesting Chlorophyll a/b/-Protein Complexes in Barley Leaves
TNSN01128A1 (en) Process for the preparation of a neutrophil inhibitory factor